CACNA2D4
Voltage-dependent calcium channel subunit alpha-2/delta-4
Also known as: alpha2delta-4, CA2D4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z3S7
- Gene
- CACNA2D4
- Ensembl
- ENSG00000151062
- Chromosome
- 12
- Canonical length
- 1137 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Mid piece,Principal piece
OverviewNCBI Gene
This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1137 residues, UniProt reviewed canonical sequence.
>Q7Z3S7|CACNA2D4
1 MVCGCSALLP LPNPRPTMPA TPNFLANPSS SSRWIPLQPM PVAWAFVQKT SALLWLLLLG
61 TSLSPAWGQA KIPLETVKLW ADTFGGDLYN TVTKYSGSLL LQKKYKDVES SLKIEEVDGL
121 ELVRKFSEDM ENMLRRKVEA VQNLVEAAEE ADLNHEFNES LVFDYYNSVL INERDEKGNF
181 VELGAEFLLE SNAHFSNLPV NTSISSVQLP TNVYNKDPDI LNGVYMSEAL NAVFVENFQR
241 DPTLTWQYFG SATGFFRIYP GIKWTPDENG VITFDCRNRG WYIQAATSPK DIVILVDVSG
301 SMKGLRMTIA KHTITTILDT LGENDFINII AYNDYVHYIE PCFKGILVQA DRDNREHFKL
361 LVEELMVKGV GVVDQALREA FQILKQFQEA KQGSLCNQAI MLISDGAVED YEPVFEKYNW
421 PDCKVRVFTY LIGREVSFAD RMKWIACNNK GYYTQISTLA DTQENVMEYL HVLSRPMVIN
481 HDHDIIWTEA YMDSKLLSSQ AQSLTLLTTV AMPVFSKKNE TRSHGILLGV VGSDVALREL
541 MKLAPRYKLG VHGYAFLNTN NGYILSHPDL RPLYREGKKL KPKPNYNSVD LSEVEWEDQA
601 ESLRTAMINR ETGTLSMDVK VPMDKGKRVL FLTNDYFFTD ISDTPFSLGV VLSRGHGEYI
661 LLGNTSVEEG LHDLLHPDLA LAGDWIYCIT DIDPDHRKLS QLEAMIRFLT RKDPDLECDE
721 ELVREVLFDA VVTAPMEAYW TALALNMSEE SEHVVDMAFL GTRAGLLRSS LFVGSEKVSD
781 RKFLTPEDEA SVFTLDRFPL WYRQASEHPA GSFVFNLRWA EGPESAGEPM VVTASTAVAV
841 TVDKRTAIAA AAGVQMKLEF LQRKFWAATR QCSTVDGPCT QSCEDSDLDC FVIDNNGFIL
901 ISKRSRETGR FLGEVDGAVL TQLLSMGVFS QVTMYDYQAM CKPSSHHHSA AQPLVSPISA
961 FLTATRWLLQ ELVLFLLEWS VWGSWYDRGA EAKSVFHHSH KHKKQDPLQP CDTEYPVFVY
1021 QPAIREANGI VECGPCQKVF VVQQIPNSNL LLLVTDPTCD CSIFPPVLQE ATEVKYNASV
1081 KCDRMRSQKL RRRPDSCHAF HPEENAQDCG GASDTSASPP LLLLPVCAWG LLPQLLRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CACNA2D4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- retina: 19 nTPM
- blood vessel: 0.4 nTPM
- tongue: 0.4 nTPM
- duodenum: 0.3 nTPM
- placenta: 0.3 nTPM
- adipose tissue: 0.2 nTPM
Single-cell type
- late spermatids: 124 nCPM
- early spermatids: 52 nCPM
- monocytes: 12 nCPM
- hofbauer cells: 11 nCPM
- cone photoreceptor cells: 8.3 nCPM
- macrophages: 6.4 nCPM
Immune cell
- classical monocyte: 4.4 nTPM
- MAIT T-cell: 4.2 nTPM
- myeloid DC: 2.9 nTPM
- gdT-cell: 2.1 nTPM
- intermediate monocyte: 1.7 nTPM
- memory CD8 T-cell: 1.5 nTPM
Brain region
- thalamus: 0.6 nTPM
- medulla oblongata: 0.4 nTPM
- pons: 0.3 nTPM
- cerebral cortex: 0.2 nTPM
- choroid plexus: 0.2 nTPM
- hypothalamus: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CACNA2D4.
Disease | AllUniProt
Conditions CACNA2D4 is implicated in, by any mechanism.
- Retinal cone dystrophy 4 (RCD4) MIM:610478
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 1,351 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Retinal cone dystrophy 4
- Cone dystrophy
- Retinal dystrophy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.75
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- von Willebrand factor, type A
- VWA N-terminal
- Voltage-dependent calcium channel, alpha-2/delta subunit, conserved region
- von Willebrand factor A-like domain superfamily
- Voltage-dependent calcium channel subunit alpha-2/delta
- VWA N-terminal
- Neuronal voltage-dependent calcium channel alpha 2acd
- von Willebrand factor type A domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CACNA2D4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CACNA2D4 as an antibody target. Whether an autoantibody or antibody against CACNA2D4 could matter depends on whether native CACNA2D4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CACNA2D4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CACNA2D4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...